Search

everythinglearnresearchcommunity

for

Search:↓

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Dermatologic surgery has advanced in reconstructive techniques and treatments for hair loss and facial paralysis.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

Combining herbal medicines with modern delivery systems may improve alopecia treatment.

Combining stem cells with ATP significantly boosts hair regrowth in mice with hair loss.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Nano-phytopharmaceuticals show promise but need more research for safe, effective use in treating certain disorders.

The new nanosilver treatment effectively kills bacteria and speeds up wound healing with less toxicity.

Ubiquitin, a protein, is found in hair, nails, and skin.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Niosomes are effective carriers for targeted drug delivery, improving drug stability and efficiency.

Spanlastics can improve drug delivery by effectively penetrating biological membranes.

Macrophages are essential for successful skin growth in reconstructive surgery.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Cepharanthine could be a strong antiviral against COVID-19.